Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Poca
2017-004967-11Phase 3Active
- Sponsor
- CHU de Nantes
- Start
- Apr 2018
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of fecal microbiome transplant in pouchitis and autoimmune colitis (2 arms), sponsored by CHU de Nantes. Primary endpoint: Time to clinical and endoscopic relapse. Started Apr 2018; status: active.
02
Drugs
fecal microbiome transplant
03
Conditions
pouchitisautoimmune colitis
Beyond the preview
Go deeper on 2017-004967-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004967-11.